FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094701891> ?p ?o ?g. }

• W2094701891 endingPage "829" @default.
• W2094701891 startingPage "829" @default.
• W2094701891 abstract "Renal cell carcinoma (RCC) may develop as a second malignancy after the treatment of acute promyelocytic leukemia (APL), Wilms tumor and non-Hodgkin's lymphoma. We report two adults who developed APL and RCC in close temporal proximity. While it is possible that the two malignancies were unrelated and may be coincidental, we speculate that there is a nonrandom association. This association, to the best of our knowledge, has not been reported previously in adults. A 64-year-old woman was diagnosed with APL in July 2006. She was treated with daunorubicin, doxorubicin, and all-trans retinoic acid (ATRA). A computed tomography (CT) scan of the chest showed an incidental left renal mass. A radical nephrectomy performed in December 2006 showed a RCC. Cytogenetics confirmed the t(15;17) translocation. The consolidation therapy consisted of daunorubicin and ATRA in October 2006. She achieved a complete molecular remission. A colonoscopy done for diarrhea revealed a polyp with adenocarcinoma. No additional therapy for APL was considered because of the time needed for the recovery from colon cancer. She remains disease free, from both APL and RCC. A 58-year-old man underwent a bone marrow biopsy for pancytopenia in December 2005 that revealed hypercellularity, promyelocytes, and Auer rods. A diagnosis of APL was made. Cytogenetics confirmed the t(15;17) translocation. The induction chemotherapy consisted of cytarabine, idarubicin, and ATRA. A CT of the abdomen in January 2006 identified an incidental left renal mass which was absent 2 years previously. He received two cycles of consolidation chemotherapy with Idarubicin in March and May 2006 and attained a complete molecular remission. He was started on ATRA, 6-mercaptopurine and methotrexate as maintenance therapy. In January 2007, a CT scan of the chest showed pulmonary nodules. Biopsy confirmed adenocarcinoma consistent with metastatic RCC. He was treated with sunitinib without nephrectomy. Subsequent imaging showed that the lung disease had resolved, the renal abnormality had regressed and the APL was in complete remission. RCC in Case 1 was detected 2 months after the diagnosis of APL. In the second case, RCC was diagnosed during the induction phase of the treatment of APL and a CT scan done 2 years earlier demonstrated the absence of a renal mass. In both the cases, ATRA was a part of the initial therapy. The occurrence of second malignancies after chemotherapy has been postulated to be due to mutations induced by cytotoxic chemotherapy. Taking into account the immunology of RCC and the effect of ATRA on the immune system, it is possible that ATRA or the chemotherapeutic regimen for APL has a role in the development or RCC in a short period of time. It seems less likely that the RCCs observed here were therapy-related because of the short time from treatment to diagnosis. An alternative explanation may be that the altered immunologic milieu provided fertile ground for the development of both diseases. A literature review reveals that RCC developing after the treatment of APL has been reported only by Huang et al. [1]. The cases reported here add to the growing body of evidence that RCC can occur as a second malignancy during or after the treatment of APL or can be related to the progression of APL and highlights the need for close monitoring after the treatment of either cancer. Alternatively, the expression and secretion of pro-angiogenic and proliferative cytokines by the renal tumor may play a role in the development of the leukemia. Ritesh Parajuli*, Jessica K. Altman*, Timothy Kuzel*, Maria Perdekamp , Martin S. Tallman , * Northwestern University Feinberg School of Medicine, Hematology-Oncology, Chicago, IL, Decatur Memorial Hospital, Hematology-Oncology, Decater, IL, Memorial Sloan Kettering Cancer Center, Leukemia Service, Division of Hematologic Oncology, New York, NY." @default.
• W2094701891 created "2016-06-24" @default.
• W2094701891 creator A5001124933 @default.
• W2094701891 creator A5003177689 @default.
• W2094701891 creator A5025780450 @default.
• W2094701891 creator A5054142179 @default.
• W2094701891 creator A5055802953 @default.
• W2094701891 date "2010-08-18" @default.
• W2094701891 modified "2023-09-25" @default.
• W2094701891 title "Renal cell carcinoma and acute promyelocytic leukemia: A nonrandom association?" @default.
• W2094701891 cites W2335571848 @default.
• W2094701891 doi "https://doi.org/10.1002/ajh.21813" @default.
• W2094701891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20721888" @default.
• W2094701891 hasPublicationYear "2010" @default.
• W2094701891 type Work @default.
• W2094701891 sameAs 2094701891 @default.
• W2094701891 citedByCount "2" @default.
• W2094701891 countsByYear W20947018912015 @default.
• W2094701891 countsByYear W20947018912016 @default.
• W2094701891 crossrefType "journal-article" @default.
• W2094701891 hasAuthorship W2094701891A5001124933 @default.
• W2094701891 hasAuthorship W2094701891A5003177689 @default.
• W2094701891 hasAuthorship W2094701891A5025780450 @default.
• W2094701891 hasAuthorship W2094701891A5054142179 @default.
• W2094701891 hasAuthorship W2094701891A5055802953 @default.
• W2094701891 hasConcept C104317684 @default.
• W2094701891 hasConcept C126322002 @default.
• W2094701891 hasConcept C142724271 @default.
• W2094701891 hasConcept C143998085 @default.
• W2094701891 hasConcept C185592680 @default.
• W2094701891 hasConcept C2775934546 @default.
• W2094701891 hasConcept C2776601000 @default.
• W2094701891 hasConcept C2776694085 @default.
• W2094701891 hasConcept C2777472916 @default.
• W2094701891 hasConcept C2778041864 @default.
• W2094701891 hasConcept C2778461978 @default.
• W2094701891 hasConcept C2779117419 @default.
• W2094701891 hasConcept C2779382419 @default.
• W2094701891 hasConcept C2779399171 @default.
• W2094701891 hasConcept C2780007613 @default.
• W2094701891 hasConcept C2780091579 @default.
• W2094701891 hasConcept C2780227381 @default.
• W2094701891 hasConcept C2781121885 @default.
• W2094701891 hasConcept C55493867 @default.
• W2094701891 hasConcept C71924100 @default.
• W2094701891 hasConcept C90924648 @default.
• W2094701891 hasConceptScore W2094701891C104317684 @default.
• W2094701891 hasConceptScore W2094701891C126322002 @default.
• W2094701891 hasConceptScore W2094701891C142724271 @default.
• W2094701891 hasConceptScore W2094701891C143998085 @default.
• W2094701891 hasConceptScore W2094701891C185592680 @default.
• W2094701891 hasConceptScore W2094701891C2775934546 @default.
• W2094701891 hasConceptScore W2094701891C2776601000 @default.
• W2094701891 hasConceptScore W2094701891C2776694085 @default.
• W2094701891 hasConceptScore W2094701891C2777472916 @default.
• W2094701891 hasConceptScore W2094701891C2778041864 @default.
• W2094701891 hasConceptScore W2094701891C2778461978 @default.
• W2094701891 hasConceptScore W2094701891C2779117419 @default.
• W2094701891 hasConceptScore W2094701891C2779382419 @default.
• W2094701891 hasConceptScore W2094701891C2779399171 @default.
• W2094701891 hasConceptScore W2094701891C2780007613 @default.
• W2094701891 hasConceptScore W2094701891C2780091579 @default.
• W2094701891 hasConceptScore W2094701891C2780227381 @default.
• W2094701891 hasConceptScore W2094701891C2781121885 @default.
• W2094701891 hasConceptScore W2094701891C55493867 @default.
• W2094701891 hasConceptScore W2094701891C71924100 @default.
• W2094701891 hasConceptScore W2094701891C90924648 @default.
• W2094701891 hasIssue "10" @default.
• W2094701891 hasLocation W20947018911 @default.
• W2094701891 hasLocation W20947018912 @default.
• W2094701891 hasOpenAccess W2094701891 @default.
• W2094701891 hasPrimaryLocation W20947018911 @default.
• W2094701891 hasRelatedWork W181858759 @default.
• W2094701891 hasRelatedWork W1971698933 @default.
• W2094701891 hasRelatedWork W2002493774 @default.
• W2094701891 hasRelatedWork W2089659534 @default.
• W2094701891 hasRelatedWork W2144969304 @default.
• W2094701891 hasRelatedWork W2151934335 @default.
• W2094701891 hasRelatedWork W2271311441 @default.
• W2094701891 hasRelatedWork W2335158968 @default.
• W2094701891 hasRelatedWork W2404917739 @default.
• W2094701891 hasRelatedWork W2891757930 @default.
• W2094701891 hasVolume "85" @default.
• W2094701891 isParatext "false" @default.
• W2094701891 isRetracted "false" @default.
• W2094701891 magId "2094701891" @default.
• W2094701891 workType "article" @default.